The Evidence for Contraceptive Options and HIV Outcomes, (ECHO) consortium — led by FHI 360 — released study data indicating that there is no substantial difference in HIV risk among three highly effective methods of contraception. Tim Mastro, Chief Science Officer at FHI 360 and ECHO Management Committee member, said, “We hope that the ECHO results will be used to expand, not restrict, women’s options for contraception.”
Home | External Articles | Reassuring contraceptives and HIV trail also a wake-upcall, experts say